Cathie Wood’s ARK ETF has made some changes to its portfolio, adding 10X Genomics and selling Rocket Lab. This move comes as part of the ongoing adjustments made by the popular ETF managed by Wood’s firm, ARK Investment Management.
10X Genomics is a company that specializes in developing tools for biological research, particularly in the field of genomics. The addition of this stock to ARK’s portfolio indicates Wood’s confidence in the potential growth and innovation within the genomics industry.
On the other hand, Rocket Lab, a company focused on providing launch services for small satellites, has been sold off by ARK ETF. This decision may have been influenced by various factors such as performance, market conditions, or shifts in investment strategy.
Overall, these adjustments reflect ARK’s active management approach, where investments are regularly reviewed and modified based on research and analysis. Wood’s ARK ETF continues to attract attention for its forward-thinking investment strategies and focus on disruptive technologies.